Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zongyi Hu

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Communications Biology|May 24, 2023
SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotypeSeung Bum Park, Mohsin Khan, Sai Chaitanya Chiliveri, et al.
Plos Pathogens|May 24, 2014
Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycleQisheng Li, Yong-Yuan Zhang, Stephan Chiu, et al.
Gastroenterology|April 28, 2009
Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entryTakuya Matsumura, Zongyi Hu, Takanobu Kato, et al.
ACS Medicinal Chemistry Letters|August 16, 2021
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike ProteinXin Hu, Catherine Z Chen, Miao Xu, et al.
Journal of Virology|December 15, 2022
Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic AnalysisTapan Kanai, Zongyi Hu, Renbin Yang, et al.
Mbio|January 11, 2022
Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule InhibitorsSeung Bum Park, Parker Irvin, Zongyi Hu, et al.
Journal of Virology|January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cellsHeidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.
Journal of Medicinal Chemistry|November 25, 2015
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus InfectionShanshan He, Jingbo Xiao, Andrés E Dulcey, et al.
Cell Chemical Biology|May 11, 2020
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1Zongyi Hu, Adam Rolt, Xin Hu, et al.
Antiviral Research|October 31, 2015
Identification of novel anti-hepatitis C virus agents by a quantitative high throughput screen in a cell-based infection assayZongyi Hu, Xin Hu, Shanshan He, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Communications Biology|May 24, 2023
SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotypeSeung Bum Park, Mohsin Khan, Sai Chaitanya Chiliveri, et al.
Plos Pathogens|May 24, 2014
Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycleQisheng Li, Yong-Yuan Zhang, Stephan Chiu, et al.
Gastroenterology|April 28, 2009
Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entryTakuya Matsumura, Zongyi Hu, Takanobu Kato, et al.
ACS Medicinal Chemistry Letters|August 16, 2021
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike ProteinXin Hu, Catherine Z Chen, Miao Xu, et al.
Journal of Virology|December 15, 2022
Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic AnalysisTapan Kanai, Zongyi Hu, Renbin Yang, et al.
Mbio|January 11, 2022
Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule InhibitorsSeung Bum Park, Parker Irvin, Zongyi Hu, et al.
Journal of Virology|January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cellsHeidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.
Journal of Medicinal Chemistry|November 25, 2015
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus InfectionShanshan He, Jingbo Xiao, Andrés E Dulcey, et al.
Cell Chemical Biology|May 11, 2020
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1Zongyi Hu, Adam Rolt, Xin Hu, et al.
Antiviral Research|October 31, 2015
Identification of novel anti-hepatitis C virus agents by a quantitative high throughput screen in a cell-based infection assayZongyi Hu, Xin Hu, Shanshan He, et al.
Pageof 4